Is Avantor, Inc. (AVTR) a Buy, Sell, or Hold?
Avantor, Inc.
NYSE:AVTR
$11.29 USD
$0.0 (-0.0%)
- Volume
- 5.04M
- Average Volume
- 9.67M
- Market Capitalization
- $7.71B
- P/E Ratio
- -14.04
- Dividend Yield
- 0.00%
- Price Target
- $9.50
- Year High
- $15.93
- Year Low
- $7.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.76
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Emmanuel Ligner |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Current Symbol | AVTR |
| CUSIP | 05352A100 |
| CIK | 0001722482 |
| Web | https://www.avantorsciences.com |
| Phone | 610 386 1700 |
| Currency | USD |
| Employees | 13500 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.68 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.76 |
| Quick Ratio | 1.17 |
| Cash Ratio | 0.20 |
Sales & Book Value
| Annual Sales | $6.55B |
| Price / Sales | 1.18 |
| Cash Flow | 0.65 |
| Price / Cash Flow | 17.56 |
| Price / Book | 1.37 |
Price Target and Rating
| Average Stock Price Forecast | $9.50 |
| High Stock Price Forecast | $11.00 |
| Low Stock Price Forecast | $7.00 |
| Forecast Upside/Downside | 18.84% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 26 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.78 |
| Trailing P/E Ratio | -14.04 |
| PEG Ratio | 0.28 |
| P/E Growth | 0.28 |
| Net Income | $-530.2M |
| Net Margin | -8.42% |
| Pretax Margin | -7.20% |
| Return on Equity | -9.59% |
| Return on Assets | -4.73% |
Financials Score
| AltmanZ Score | 1.50 |
| Piotroski Score | 5.00 |
| Working Capital | 1.04B |
| Total Assets | 11.66B |
| Ebit | -288.6M |
| Market Cap | 7.2B |
| Total Liabilities | 6.07B |
Poll Results
About Avantor, Inc. (NYSE:AVTR) Stock
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic ... pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
2026-07-15 13:10:28
Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
2026-07-15 10:05:24
AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
2026-07-14 08:05:00
RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion of a collaboration between its NuSil® brand, a premier global manufacturer of high-purity silicones suitable for use in medical devices and drug-device combination products, and the Population Council, an international nonprofit research organization, to support the development of the Council's new three-month dapivirine vaginal ring for HIV prevention.
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
2026-07-09 14:25:35
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
2026-07-01 08:05:00
RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
2026-05-29 12:32:10
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
2026-05-29 12:11:05
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
2026-05-19 06:05:00
RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Frequently Asked Questions
-
What is the current Avantor, Inc. (AVTR) stock price?
-
Avantor, Inc.(NYSE:AVTR) stock price is $11.29 in the last trading session. During the trading session, AVTR stock reached the peak price of $15.93 while $7.265 was the lowest point it dropped to. The percentage change in AVTR stock occurred in the recent session was --0.0% while the dollar amount for the price change in AVTR stock was -$-0.0.
-
AVTR's industry and sector of operation?
-
The NYSE listed AVTR is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.
-
Who are the executives of AVTR?
-
Corey D. Walker | President of Laboratory Solutions
Emmanuel Ligner | President, Chief Executive Officer & Director
Michael Wondrasch | Executive Vice President & Chief Information Officer
R. Brent Jones | Executive Vice President & Chief Financial Officer
Benoit Gourdier | Executive Vice President of Bioscience Production -
How many employees does AVTR have?
-
Number of AVTR employees currently stands at 13500. AVTR operates from Radnor Corporate Center, Radnor, PA 19087, US.
-
Link for AVTR official website?
-
Official Website of AVTR is: https://www.avantorsciences.com
-
How do I contact AVTR?
-
AVTR could be contacted at phone #610 386 1700 and can also be accessed through its website. AVTR operates from Radnor Corporate Center, Radnor, PA 19087, US.
-
How many shares of AVTR are traded daily?
-
The average number of AVTR shares traded daily for last 3 months was 9.67M.
-
What is the market cap of AVTR currently?
-
The market value of AVTR currently stands at $7.71B with its latest stock price at $11.29